MeSH tree: C20.111.327
Diabetes is one of the most common chronic diseases, affecting around 66 million adults in Europe—a figure projected to rise to more than 72 million by 2050. For people with type 1 diabetes, keeping glucose levels within ...
16 hours ago
0
3
Seven years ago, Johns Hopkins researchers and their collaborators announced they had found the X cell, a novel immune cell that plays a key role in the development of type 1 diabetes.
19 hours ago
0
6
New research presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy, shows that people who have had COVID-19 have a lower, rather than higher, risk of subsequently developing ...
23 hours ago
0
6
The number of people living with type 1 diabetes worldwide is projected to jump nearly 30% over the next two decades, from 9.4 million today to 12.1 million by 2049.
Sep 1, 2026
0
6
New research presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept. 28–Oct. 2) estimates that the number of people living with type 1 diabetes (T1D) worldwide will ...
Aug 28, 2026
0
10
Type 2 diabetes has traditionally been a disease that has affected mostly middle-aged and older adults. But new research from the U.S. to be presented at the Annual Meeting of the European Association for the Study of Diabetes ...
Aug 23, 2026
0
9
A UIC study led by kinesiology and nutrition professor Krista Varady found that time-restricted eating may be a safe, effective tool to control blood sugar in adults with type 1 diabetes. The work is published in the journal ...
Aug 20, 2026
0
203
Insulin is a cornerstone of treatment for patients with type 1 diabetes, essential for lowering blood glucose levels. However, if insulin doses are not appropriately matched to the body's needs, glucose levels can fall too ...
Aug 18, 2026
0
13
Continuous glucose monitors (CGMs) were originally developed for people with type 1 diabetes and are now widely used by many people with type 2 diabetes. In recent years, the technology has become an increasingly popular ...
Aug 4, 2026
0
7
An international research group led by researchers from VUB-UZ Brussels and KU Leuven has demonstrated that a combined approach targeting both the immune system and insulin-producing beta cells can slow the progression of ...
Jul 14, 2026
0
3
